These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 30343342

  • 1. IgG levels in Kawasaki disease and its association with clinical outcomes.
    Yamazaki-Nakashimada MA, Gámez-González LB, Murata C, Honda T, Yasukawa K, Hamada H.
    Clin Rheumatol; 2019 Mar; 38(3):749-754. PubMed ID: 30343342
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 3. Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG.
    Goto R, Inuzuka R, Shindo T, Namai Y, Oda Y, Harita Y, Oka A.
    Clin Rheumatol; 2020 Dec; 39(12):3747-3755. PubMed ID: 32458247
    [Abstract] [Full Text] [Related]

  • 4. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 5. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Oct; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 6. The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.
    Kim HJ, Choi EH, Lim YJ, Kil HR.
    J Korean Med Sci; 2017 Jul; 32(7):1147-1153. PubMed ID: 28581272
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
    Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.
    Int Arch Allergy Immunol; 2014 Jul; 164(2):83-8. PubMed ID: 24903098
    [Abstract] [Full Text] [Related]

  • 8. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
    Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
    [Abstract] [Full Text] [Related]

  • 9. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 10. Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease.
    Nakada T.
    Pediatr Cardiol; 2015 Feb 15; 36(2):335-9. PubMed ID: 25158631
    [Abstract] [Full Text] [Related]

  • 11. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 15; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 12. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome.
    Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, De Nisco A, Angelone DF, Compagnone A, Delogu AB.
    Rheumatol Int; 2010 Apr 15; 30(6):841-6. PubMed ID: 20049445
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 15; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 14. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 15. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y.
    Circ J; 2015 Jul 19; 79(6):1349-56. PubMed ID: 25787672
    [Abstract] [Full Text] [Related]

  • 16. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
    Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
    Pediatr Int; 2016 Mar 19; 58(3):180-184. PubMed ID: 26222760
    [Abstract] [Full Text] [Related]

  • 17. Coronary artery status of patients with transient fever 24-36 h after first IVIG infusion did not differ from that seen in responsive patients.
    Baek JS, Yu JJ, Kim MJ, You J, Jun HO, Kim YH, Ko JK.
    Pediatr Rheumatol Online J; 2018 Dec 29; 16(1):83. PubMed ID: 30594188
    [Abstract] [Full Text] [Related]

  • 18. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
    Arch Dis Child; 2011 Nov 29; 96(11):1088-90. PubMed ID: 20551193
    [Abstract] [Full Text] [Related]

  • 19. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
    Cho HJ, Bak SY, Kim SY, Yoo R, Baek HS, Yang S, Hwang IT, Ban JE.
    Pediatr Int; 2017 Jun 29; 59(6):669-674. PubMed ID: 28097746
    [Abstract] [Full Text] [Related]

  • 20. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B, Koné-Paut I, Yager H, Bourgeois FL, Piram M.
    Rheumatology (Oxford); 2021 Oct 02; 60(10):4530-4537. PubMed ID: 33493353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.